ArticleTranslational cancer research2026
Development and internal validation of a prognostic nomogram for cancer-specific survival among elderly unresected colorectal cancer patients receiving chemotherapy: a retrospective SEER database study.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Colorectal cancer (CRC) is common among older adults, and a substantial proportion of elderly patients are unable to undergo surgical resection because of advanced disease, comorbidities, or poor physical condition. Although chemotherapy is an important treatment option for these patients, their survival outcomes are highly heterogeneous. Therefore, this study aimed to identify prognostic factors and develop an internally validated nomogram to predict cancer-specific survival (CSS) in elderly patients with unresected CRC receiving chemotherapy. Methods: Clinical variables were sourced from the Surveillance, Epidemiology, and End Results (SEER) database, encompassing 2005 elderly CRC (ECRC) patients who underwent chemotherapy without surgery from 2004 to 2019. Cox regression analysis was conducted to identify prognostic factors, which were then utilized to construct the nomogram. The nomogram was validated using receiver operating characteristic (ROC) curves and calibration plots. Results: The study identified seven prognostic factors, including tumor grade, bone metastasis, metastasis stage (M stage), race, tumor location, carcinoembryonic antigen (CEA) levels, and tumor stage (T stage), which were incorporated into the nomogram. The ROC curves demonstrated areas under the ROC curve (AUCs) of 0.705, 0.756, and 0.797 for predicting CSS at 1, 3, and 5 years in the training cohort, and 0.714, 0.822, and 0.807 in the validation cohort. Calibration plots revealed a high degree of concordance between observed and predicted CSS at 1, 3, and 5 years. Conclusions: The nomogram for predicting CSS in elderly patients with unresected CRC undergoing chemotherapy significantly enhances the precision of treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.